When Fear Spikes, These 5 Quiet, Overlooked Stocks Keep Delivering
3. Medtronic
Medtronic (NYSE: MDT) is the classic defensive healthcare play. Though the stock is down 2.39% year-over-year and 5.37% lower year-to-date, this is the most subdued performer on this list. But that's not the point. In its most recent quarter, revenue grew 8.74% year-over-year to $9.017 billion, with cardiovascular up 13.8% and diabetes up 14.8%. Beta is just 0.729. The dividend tells the real story: Medtronic has paid and grown its quarterly dividend without interruption for 25+ years, with the current quarterly payment at $0.71 per share. Analysts carry a consensus target of $111.69 against a current price near $90.90. The combination of low beta, consistent dividend growth, and steady revenue makes it a frequently cited name in defensive market discussions.
2. Fortis
Fortis (NYSE: FTS) is the quietest compounder on the list. The Canadian regulated utility operates across five Canadian provinces, 10 U.S. states, and the Caribbean, with $75 billion in total assets. Its beta of 0.443 is among the lowest in the market. Last week, when the S&P 500 fell nearly 2%, Fortis gained 0.49%. It's up 30.46% over one year and 10.94% year-to-date. The dividend record is exceptional, with a streak of more than 50 years of annual increases. The most recent quarterly dividend was $0.469 per share (ex-dividend February 17, 2026), with a current dividend yield of 4.34%. In a market this anxious, Fortis holds its ground.
1. Ameren
Ameren (NYSE: AEE) is the top-ranked safe haven here, and the price action backs it up. While the broader market has retreated, Ameren is up 6.12% over the past month alone, 11.68% year-to-date, and 14.80% over the past year. The Missouri and Illinois regulated utility posted full-year 2025 operating cash flow of $3.353 billion and guided for 2026 EPS of $5.25 to $5.45, with a long-term target of 6% to 8% EPS CAGR through 2030 backed by a $31.8 billion infrastructure investment plan. The quarterly dividend has grown from $0.55 in 2021 to $0.71 in 2025, with no interruptions. Beta is just 0.531. An additional tailwind is the growing demand for grid expansion from AI data centers, which gives Ameren a long-term growth story typically associated with technology companies.
Boring Is Beautiful Right Now
When the VIX climbs, consumer confidence crumbles, and markets price in elevated risk, the stocks that hold their value rarely dominate financial media. This list spans regulated utilities, a medical device stalwart, a volatility-benefiting brokerage, and an infrastructure giant in recovery mode. Each has a different mechanism for weathering uncertainty, but all share one trait: they keep doing their job regardless of the headlines.
The analyst who called NVIDIA in 2010 just named his top 10 AI stocks
Wall Street is pouring billions into AI, but most investors are buying the wrong stocks. The analyst who first identified NVIDIA as a buy back in 2010 — before its 28,000% run — has just pinpointed 10 new AI companies he believes could deliver outsized returns from here. One dominates a $100 billion equipment market. Another is solving the single biggest bottleneck holding back AI data centers. A third is a pure-play on an optical networking market set to quadruple. Most investors haven't heard of half these names. Get the free list of all 10 stocks here.
Content Original Link:
" target="_blank">
